R3CE is a clinically validated 3D single-cell culture platform and can seize the golden window of cancer treatment for patients!
Since cancer cells proliferate and mutate quickly, patients typically have to test a variety of medication to find an effective treatment. Each round of testing typically takes three to six months. However, with R3CE serving as a single-cell proliferation platform, patients’ cancer cells can be cultured in-vitro. This will allow doctors to find effective remedies for patients.
Advantages of R3CE Technology Platform:
Functional on different plate types
Ease of observation due to transparent substrate
Enables analysis and culturing of various biological cells.
Spheroids cultured are highly uniform and 400 times the size of the original sample cells after 7 days of proliferation.
Clinically validated single cell amplification platform.
Similar protocol to 2D cultures
Cultures are easy to maintain and can be sampled through treatment-free processes.
Spheroids are oftentimes a more accurate representation of the human body’s reactions and conditions.
Accurately predicts drug candidates and provides result in three weeks. These results were obtained through double-blind experiments with prestigious international clinical centers.
Animal 3D tumor cells cultured by R3CE proliferate faster than 2D cultures and can be used in experiments.
Hospitals, research labs, medical centers, technical cooperation, precision medicine and tumor related research and testing